MRNA Jan 2024 110.000 call
| Previous close | 62.10 |
| Open | 62.10 |
| Bid | 64.20 |
| Ask | 68.85 |
| Strike | 110.00 |
| Expiry date | 2024-01-19 |
| Day's range | 62.10 - 62.10 |
| Contract range | N/A |
| Volume | |
| Open interest | 56 |
- Zacks
FDA Recommends Adding New Omicron Subvariants to COVID Boosters
In anticipation of a new surge of COVID-19 infections later this year, the FDA recommends that COVID-19 vaccine manufacturers develop bivalent booster vaccines that contain the BA.4/BA.5 Omicron subvariants.
- Motley Fool
Why This Company Could See Long-Lasting Tailwinds Despite the Bear Market
Life sciences company Thermo Fisher Scientific (NYSE: TMO) played an instrumental role in delivering COVID-19 treatments to the world's population. With healthcare spending on the rise, Thermo Fisher is expanding its services in a bid to capture even more of the market. To help address this need, The White House released a Pandemic Preparedness Plan and hopes to increase biodefense spending.
- Yahoo Finance Video
FDA backs adjusting COVID booster to new variants, RH and TSM stocks down
Yahoo Finance Live looks at several of the day's trending stocks, including volatility in the semiconductor industry and Pfizer and Moderna opting to enhance COVID-19 booster shots to provide protection against new subvariants.
